[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338764-105":59,"doc-detail-338764-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pik3ca-mutation-fortifies-molecular-determinants-for-immune-signaling-in-vascular-cancers","PIK3CA mutation fortifies molecular determinants for immune signaling in vascular cancers","","PIK3CA mutations are oncogenic alterations that disrupt the PI3K signaling axis in vascular cancers. This study defines molecular and functional consequences of oncogenic PIK3CA H1047R mutations in angiosarcoma by generating isogenic hemangiosarcoma cell lines via CRISPR/Cas9. PIK3CA-mutant cells display distinct global gene-expression and chromatin-accessibility programs enriched for immune cytokine signaling (including IL-6, IL-8, and MCP-1), with processes disrupted by the PI3K-α inhibitor alpelisib. Multi-omics links these changes to metabolic reprogramming and identifies MAPK-mediated therapeutic vulnerabilities that contribute to resistance to alpelisib.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pik3ca-mutation-fortifies-molecular-determinants-for-immune-signaling-in-vascular-cancers/338764/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pik3ca-mutation-fortifies-molecular-determinants-for-immune-signaling-in-vascular-cancers/338764.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study investigate about PIK3CA mutations in vascular cancers?","Question",{"text":112,"@type":113},"The study investigates how oncogenic PIK3CA mutations affect molecular and functional programs that drive immune signaling and drug response in angiosarcoma/hemangiosarcoma models.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the experimental models for PIK3CA H1047R generated?",{"text":117,"@type":113},"The researchers used CRISPR/Cas9 gene editing to introduce the H1047R hotspot mutation in hemangiosarcoma cell lines, creating isogenic models for comparison.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune-related changes were observed in PIK3CA-mutant cells, and what did alpelisib do?",{"text":121,"@type":113},"PIK3CA-mutant cells developed distinct gene-expression and chromatin-accessibility signatures enriched for immune cytokine signaling, including IL-6, IL-8, and MCP-1. These molecular immune processes were disrupted by the PI3K-α specific inhibitor alpelisib.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338764,1790167610,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","[www.nature.com/cgt](www.nature.com/cgt) Cancer Gene Therapy  \nARTICLE OPEN   \nPIK3CA mutation fortiﬁes molecular determinants for immune signaling in vascular cancers  \nDonghee Lee 1, Emma C. Kozurek 2,3,4, Md Abdullah 1, Ethan J. Wong2,3,4, Rong Li 1, Zhiyan Silvia Liu5, Hai Dang Nguyen4,5, Erin B. Dickerson2,3,4 and Jong Hyuk Kim 1,6,7 ✉  \n© The Author(s) 2024  \n\n|  | Angiosarcomas are a group of vascular cancers that form malignant blood vessels. These malignancies are seemingly inﬂamed primarily due to their pathognomonic nature, which consists of irregular endothelium and tortuous blood channels. PIK3CA mutations are oncogenic and disrupt the PI3K pathway. In this study, we aimed to deﬁne the molecular and functional consequences of oncogenic PIK3CA mutations in angiosarcoma. We ﬁrst generated two isogenic hemangiosarcoma cell lines harboring the H1047R hotspot mutations in PIK3CA gene using CRISPR/Cas9 . We found PIK3CA-mutant cells established distinct molecular signatures in global gene expression and chromatin accessibility, which were associated with enrichment of immune cytokine signaling, including IL-6, IL-8, and MCP-1 . These molecular processes were disrupted by the PI3K-α speciﬁc inhibitor, alpelisib. We also observed that the molecular distinctions in PIK3CA-mutant cells were linked to metabolic reprogramming in glycolytic activity and mitochondrial respiration. Our multi-omics analysis revealed that activating PIK3CA mutations regulate molecular machinery that contributes to phenotypic alterations and resistance to alpelisib. Furthermore, we identiﬁed potential therapeutic vulnerabilities of PIK3CA mutations in response to PI3K-α inhibition mediated by MAPK signaling. In summary, we demonstrate that PIK3CA mutations perpetuate PI3K activation and reinforce immune enrichment to promote drug resistance in |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| vascular cancers. |  |  |\n|  | Cancer Gene Therapy (2025) 32:254–267; [https://doi.org/10.1038/s41417-024-00867-4](https://doi.org/10.1038/s41417-024-00867-4) |  |\n|  |  |  |\n\nINTRODUCTION  \nAngiosarcoma is an aggressive soft tissue sarcoma that forms malignant endothelium. Irregular vascular formation establishes an inﬂamed local tumor tissue, possibly due to leaky vessels, blockage of normal blood ﬂow, and excessive hemorrhage [1] . Angiosarcomas are extremely rare with ~1000 or fewer patients per year in the United States [2] . Hemangiosarcoma, a histologically identical form of angiosarcoma in animals, naturally developsin companion dogs. Unlike in humans, hemangiosarcomas are common vascular malignancy in dogs with more than 50,000 cases annually [3] . Canine hemangiosarcoma shares clinical and morphological features as well as pathogenesis with human angiosarcoma, serving as a natural cancer model [4–8] . Human patients with angiosarcoma have a 40% ﬁve-year survival rate, with half having a median overall survival of 16 months [9] . Similarly, clinical outcomes for dogs with hemangiosarcoma are unfavorable, with an average life expectancy of 6 months or less, especially when the tumor occurs in internal organs, ruptures, or metastasizes [10, 11] .  \nThe hallmark of angiosarcoma involves the creation of distorted vascular spaces by malignant cells. These spaces harbor a diverse array of blood and immune components, where a controlled scavenging system is necessary for tumor maintenance. In this  \ncontext, the ability of angiosarcoma cells to control the hematoendothelial system emerges as pivotal to their pathogenic signiﬁcance [12] . At the molecular level, recurrent mutations are found in TP53, and genes involved in phosphatidylinositol 3-kinase (PI3K) pathway such as PIK3CA, PIK3R1, and PTEN in both human angiosarcoma and canine hemangiosarcoma [13–17] . PIK3CA is a one of the most frequent cross-species oncogenic mutations, and approximately 20","cbCaijLyPf9m3jNd","https://ap.wps.com/l/cbCaijLyPf9m3jNd","pdf",27410670,14,"English","# Introduction\n## Angiosarcoma background and need for molecular insight\n## Role of PI3K pathway and PIK3CA in vascular tumors\n# Methods and experimental models\n## CRISPR/Cas9 generation of PIK3CA H1047R isogenic cell lines\n# Results\n## Immune cytokine and chemokine signaling enrichment\n## Sensitivity to PI3K-α inhibition and disruption of immune programs\n## Metabolic reprogramming and links to resistance\n## MAPK-mediated therapeutic vulnerabilities\n# Conclusion","[{\"question\":\"What question does the study investigate about PIK3CA mutations in vascular cancers?\",\"answer\":\"The study investigates how oncogenic PIK3CA mutations affect molecular and functional programs that drive immune signaling and drug response in angiosarcoma/hemangiosarcoma models.\"},{\"question\":\"How were the experimental models for PIK3CA H1047R generated?\",\"answer\":\"The researchers used CRISPR/Cas9 gene editing to introduce the H1047R hotspot mutation in hemangiosarcoma cell lines, creating isogenic models for comparison.\"},{\"question\":\"What immune-related changes were observed in PIK3CA-mutant cells, and what did alpelisib do?\",\"answer\":\"PIK3CA-mutant cells developed distinct gene-expression and chromatin-accessibility signatures enriched for immune cytokine signaling, including IL-6, IL-8, and MCP-1. These molecular immune processes were disrupted by the PI3K-α specific inhibitor alpelisib.\"}]","PIK3CA mutation fortifies molecular determinants for immune signaling in vascular cancers | PDF",1790025511,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81326623c57d4c7300eeeeef57233845.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac200a260655d95ea2597f44e9f5e134.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3f0ac03df61f675700b9e6e8026300a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44ffb3228e0ca1ff1c479e093bcc2af4.webp",980,1301]